ASX Share rice
Sat 08 Aug 2020 - 04:44:am (Sydney)

PGC Share Price

PARAGON CARE LIMITEDPGCHealth Care Equipment & Services

PGC Company Information

Name:

Paragon Care Limited

Sector:

Healthcare

Industry:

Medical Distribution

GIC Industry:

Health Care Providers & Services

GIC Sub Industry:

Health Care Distributors

Address:

50-54 Clayton Road Clayton VIC Australia 3168

Phone:

61 3 8833 7800

Chief Exec. Officer:

Mr. Phil Nicholl

Chief Financial Officer:

Mr. Stephen J. Munday

Company Sec.:

Ms. Melanie Jaye Leydin C.A., B.Bus, CA

Group Commercial Mang.:

Mr. Michael G. Rice

Company Overview:

Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. Paragon Care Limited is based in Clayton, Australia.

PGC Share Price Information

Shares Issued:

337.88M

Market Capitalisation:

$59.13M

Dividend per Share:

$0.02

Ex Dividend Date:

2019-03-21

Dividend Yield:

11.43%

Revenue (TTM):

$237.35M

Revenue Per Share (TTM):

$0.70

Earnings per Share:

$-0.045

Profit Margin:

-0.0372

Operating Margin (TTM):

$0.04

Return On Assets (TTM):

$0.02

Return On Equity (TTM):

$0.03

Quarterly Revenue Growth (YOY):

0.011

Gross Profit(TTM):

$95.10M

Diluted Earnings Per Share (TTM):

$-0.026

PGC CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-35,474,000

Change To Liabilities:

$-6,980,000

Total Cashflow From Investing Activities:

$-35,474,000

Net Borrowings:

$-5,438,000

Net Income:

$-14,386,000

Total Cash From Operating Activities:

$1.16M

Depreciation:

$8.17M

Other Cashflow From Investing Activities:

$80K

Dividends Paid:

$-8,703,000

Change To Inventory:

$-7,443,000

Change To Account Receivables:

$4.75M

Sale Purchase Of Stock:

$-2,907,000

Capital Expenditures:

$9.72M

PGC Income Statement

Income Date:

2019-06-30

Income Before Tax:

$12.19M

Net Income:

$-14,386,000

Gross Profit:

$95.10M

Operating Income:

$16.41M

Interest Expense:

$5.96M

Income Tax Expense:

$3.42M

Total Revenue:

$236.09M

Total Operating Expenses:

$114.09M

Cost Of Revenue:

$140.99M

PGC Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$8.14M

Total Liabilities:

$191.88M

Total Stockholder Equity:

$192.32M

Other Current Liabilities:

$7.46M

Total Assets:

$384.20M

Common Stock:

$202.72M

Other Current Assets:

$-33,000

Retained Earnings:

$-11,497,000

Other Liabilities:

$10.54M

Good Will:

$196.18M

Other Assets:

$7.97M

Cash:

$34.22M

Total Current Liabilities:

$72.87M

Short-Term Debt:

$4M

Property - Plant & Equipment:

$33.98M

Net Tangible Assets:

$-12,005,000

Total Current Assets:

$137.93M

Long-Term Debt:

$88.32M

Net Receivables:

$39.45M

Short-Term Investments:

$246.27M

Inventory:

$51.41M

Accounts Payable:

$40.45M

Short-Term Investments:

$246.27

Non Current Liabilities (Other):

$9.67M

Non Current Liabilities Total:

$119.01M

PGC Share Price History

PGC News

15 Jul, 2020
With a price-to-earnings (or "P/E") ratio of 11.4x Paragon Care Limited (ASX:PGC) may be sending bullish signals at...
06 May, 2020
Paragon Care (ASX:PGC) shareholders are no doubt pleased to see that the share price has bounced 42% in the last month...
23 Apr, 2020
This month, we saw the Paragon Care Limited (ASX:PGC) up an impressive 62%. But that doesn't change the fact that the...
21 Feb, 2020
Unfortunately for some shareholders, the Paragon Care (ASX:PGC) share price has dived 37% in the last thirty days...
15 Jan, 2020
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). To keep it practical, we'll...
04 Nov, 2019
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
09 Oct, 2019
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
02 Sep, 2019
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
20 Aug, 2019
Kuros Biosciences, a leader in next generation bone graft technologies, today reported its results for the first half year 2019. The Company accelerated product sales in the first half of 2019, while further decreasing administrative expenses, confirming its successful transition into a full-fledged orthobiologics company with its lead product, MagnetOs and its product candidate.

PGC Dividend Payments

EX-Date Dividend Amount
2013-10-04$0.0100
2014-03-06$0.0050
2014-10-07$0.0075
2015-03-04$0.0060
2015-08-27$0.0080
2016-03-08$0.0080
2016-09-15$0.0140
2017-03-08$0.0110
2017-09-07$0.0188
2018-03-14$0.0110
2018-09-14$0.0200
2019-03-20$0.0110

PGC Dividends (last 7 Years)